
- /
- Supported exchanges
- / US
- / SRTOY.PINK
Sartorius Stedim Biotech S.A (SRTOY PINK) stock market data APIs
Sartorius Stedim Biotech S.A Financial Data Overview
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sartorius Stedim Biotech S.A data using free add-ons & libraries
Get Sartorius Stedim Biotech S.A Fundamental Data
Sartorius Stedim Biotech S.A Fundamental data includes:
- Net Revenue: 2 858 M
- EBITDA: 668 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sartorius Stedim Biotech S.A News

Sartorius Stedim Biotech SA (SDMHF) Q1 2025 Earnings Call Highlights: Strong Bioprocess Growth ...
Sales Revenue Growth: 6.5% in constant currencies, 7.7% in reporting currencies to EUR883 million. Bioprocess Solutions Sales Growth: 10% in constant currencies to EUR718 million. Lab Products & Servi...


Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ...
Sales Revenue: EUR3.4 billion, with a slight increase of 0.1% in constant currencies. Order Intake: Increased by double digits, particularly strong in consumables. Underlying EBITDA Margin: 28.0%, equ...

Sartorius Stedim Biotech SA (SDMHF) Q3 2024 Earnings Call Highlights: Navigating Market ...
Sales Revenue: Slight decline of 1.3% in constant currencies for the first 9 months of 2024, totaling EUR 2,029 million. Order Intake: Increased by 8.5% in constant currencies, reaching EUR 2.326 bill...

Nine-month results 2022 of Sartorius Stedim Biotech
Sales revenue up 17.0 percent in constant currencies, underlying EBITDA margin at 35.0 percent Overall market situation characterized by innovations and strong growth drivers; current development as e...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.